HPV Transmission

Advaxis Completes Dosing of Vanguard Patient Group in Phase II Cervical Dysplasia Clinical Trial
NORTH BRUNSWICK, N.J.—-Advaxis, Inc., , the live, attenuated Listeria monocytogenes biotechnology company, enrolled and has administered its initial dose to its third patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia , commonly known as cervical dysplasia.

Read more on Business Wire via Yahoo! Finance

Complete Male Checkup - Comprehensive Health Assessment - Get Tested Now - 5% OFF expires Mar 15 code PCJ09

Advaxis Doses First Cervical Dysplasia Clinical Trial Patient
Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, has dosed the first patient in its US Food and Drug Administration (FDA)-approved, phase II clinical trial in cervical intraepithelial neoplasia (CIN), commonly known as cervical dysplasia. The clinical trial is slated to be a multicenter, randomized, placebo controlled, blinded clinical trial …

Read more on Medical News Today

DescriptionIn this brochure update, naturopath Dr. Jane Semple introduces you to the human papillomavirus (HPV) which causes the symptoms associated with cancer, and conventional vaccines and treatments to combat them. Regarding HPV from a holistic perspective, Dr Semple offers a naturopathic approach to nutrition, vitamins, minerals, vegetables, fruit juices, herbs and other natural food supplements. The booklet concludes with a discussion on detoxificati. . . More>>

HPV and Cervical Dysplasia: A Naturopathic Approach

the HPV again? I’m unclear on exactly what happens? I know the cone doesnt remove the hpv, just the bad cells, but can you get another cone biopsy? what if you get the dysplasia again

I’m just wondering what the outcome of you claim was and what was the process.